ArticleJournal of bone oncology2017

Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration.

Anas Nooh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.